Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 200 Total
PRTS - CarParts.com Inc - Stock Price Chart
TickerPRTS [NASD, RUT]
CompanyCarParts.com Inc
CountryUSA
IndustryInternet Retail
Market Cap65.77MEPS (ttm)-0.28
P/E-EPS this Y-182.22%
Forward P/E-EPS next Y14.96%
PEG-EPS past 5Y-0.12%
P/S0.10EPS next 5Y15.00%
P/B0.56EPS Q/Q-733.15%
Dividend-Sales Q/Q-5.24%
Insider Own5.45%Inst Own79.50%
Insider Trans1.37%Inst Trans-0.53%
Short Float6.07%EarningsMay 07/a
Analyst Recom1.67Target Price2.33
Avg Volume872.25K52W Range0.99 - 5.16
CarParts.com, Inc. operates as an online provider of aftermarket auto parts and accessories in the United States and the Philippines. Its products include Collision Parts, Engine Parts, Performance Parts and Accessories. The firm also sells auto parts to collision repair shops, markets Kool-Vue products to auto parts wholesale distributor, and aftermarket catalytic converters under the Evan Fischer brand. Its flagship Websites include www.carparts.com, www.jcwhitney.com, www.autopartswarehouse.com and www.usautoparts.com. The company was founded by Sol Khazani and Mehran Nia in 1995 and is headquartered in Carson, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lockwood RyanChief Financial OfficerMay 12 '24Option Exercise0.002,369080,998May 14 05:42 PM
GREYSON JAY KEITHDirectorMay 10 '24Buy1.0441,65843,324282,107May 14 05:23 PM
Meniane DavidChief Executive OfficerApr 18 '24Option Exercise0.0067,26101,515,850Apr 22 04:21 PM
Lockwood RyanChief Financial OfficerApr 18 '24Option Exercise0.0022,254091,109Apr 22 04:24 PM
Subramanian KalsChief Technology OfficerApr 18 '24Option Exercise0.0016,786061,994Apr 22 04:28 PM
FULC - Fulcrum Therapeutics Inc - Stock Price Chart
TickerFULC [NASD]
CompanyFulcrum Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap481.04MEPS (ttm)-1.61
P/E-EPS this Y-2.52%
Forward P/E-EPS next Y0.95%
PEG-EPS past 5Y1.09%
P/S191.65EPS next 5Y16.40%
P/B2.25EPS Q/Q-4.48%
Dividend-Sales Q/Q-100.00%
Insider Own7.05%Inst Own91.69%
Insider Trans0.88%Inst Trans23.62%
Short Float5.34%EarningsMay 13/b
Analyst Recom1.33Target Price15.78
Avg Volume608.67K52W Range2.65 - 13.70
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tourangeau GregPrincipal Accounting OfficerMay 07 '24Sale7.762361,83111,571May 09 04:10 PM
Tourangeau GregVice President, FinanceMar 08 '24Sale11.724,88457,21911,807Mar 08 06:05 PM
Sapir AlexSee RemarksMar 04 '24Buy11.3543,360492,02843,360Mar 05 04:15 PM
AKRO - Akero Therapeutics Inc - Stock Price Chart
TickerAKRO [NASD, RUT]
CompanyAkero Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.35BEPS (ttm)-3.20
P/E-EPS this Y-33.39%
Forward P/E-EPS next Y-9.41%
PEG-EPS past 5Y1.03%
P/S-EPS next 5Y-
P/B1.59EPS Q/Q-63.47%
Dividend-Sales Q/Q-
Insider Own15.97%Inst Own98.05%
Insider Trans0.49%Inst Trans15.69%
Short Float14.33%EarningsMay 10/b
Analyst Recom1.20Target Price46.78
Avg Volume1.21M52W Range11.25 - 58.38
Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young JonathanChief Operating OfficerMay 01 '24Sale20.155,000100,750258,306May 02 09:07 PM
Young JonathanChief Operating OfficerApr 01 '24Sale24.385,000121,913263,306Apr 03 06:55 PM
Cheng AndrewPresident and CEOMar 13 '24Sale28.331,96955,782589,447Mar 15 04:43 PM
White William RichardChief Financial OfficerMar 13 '24Sale28.3372420,51149,630Mar 15 04:44 PM
Yale CatrionaChief Development OfficerMar 13 '24Sale28.3372320,48377,692Mar 15 04:45 PM
TLS - Telos Corp - Stock Price Chart
TickerTLS [NASD]
CompanyTelos Corp
CountryUSA
IndustrySoftware - Infrastructure
Market Cap323.64MEPS (ttm)-0.44
P/E-EPS this Y-67.18%
Forward P/E-EPS next Y60.23%
PEG-EPS past 5Y-
P/S2.32EPS next 5Y-
P/B2.10EPS Q/Q33.69%
Dividend-Sales Q/Q-15.91%
Insider Own28.08%Inst Own61.46%
Insider Trans2.64%Inst Trans1.02%
Short Float1.73%EarningsMay 10/b
Analyst Recom2.00Target Price5.40
Avg Volume422.78K52W Range1.87 - 5.00
Telos Corp. engages in the design and provision of advanced technologies to deliver solutions that empower and protect the demanding enterprises. Its solutions include cyber security, cyber risk management and compliance, secure mobility, identity management, and information technology and enterprise solutions. The company was founded in October 1971 and is headquartered in Ashburn, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schaufeld FredrickDirectorMay 24 '24Buy3.9854,650217,507687,920May 24 04:56 PM
Schaufeld FredrickDirectorMay 22 '24Option Exercise1.8058,000104,400189,620May 22 05:25 PM
Schaufeld FredrickDirectorMay 22 '24Buy4.01100,248401,994633,270May 22 05:25 PM
Schaufeld FredrickDirectorMay 21 '24Buy3.94138,538545,840533,022May 22 05:25 PM
Schaufeld FredrickDirectorMay 20 '24Buy3.808,21931,232394,484May 22 05:25 PM
EFSH - 1847 Holdings LLC - Stock Price Chart
TickerEFSH [AMEX]
Company1847 Holdings LLC
CountryUSA
IndustryConglomerates
Market Cap7.14MEPS (ttm)-116.70
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.75%
P/S0.10EPS next 5Y-
P/B-EPS Q/Q75.91%
Dividend-Sales Q/Q-3.18%
Insider Own7.87%Inst Own0.43%
Insider Trans0.00%Inst Trans1.99%
Short Float2.39%Earnings-
Analyst Recom-Target Price-
Avg Volume285.99K52W Range1.05 - 47.28
1847 Holdings LLC engages in the acquisition and management of small businesses in different industries. It operates through the following segments: Retail and Appliances, Construction, and Automotive Supplies. The Retail and Appliances segment provides a wide variety of appliance services including sales, delivery, installation, service and repair, extended warranties, and financing. The Construction segment offers doors, door frames, base boards, crown molding, cabinetry, bathroom sinks and cabinets, bookcases, built-in closets, and fireplace mantles. The Automotive Supplies segment designs and sells horn and safety products and provides vehicle emergency and safety warning lights for cars, trucks, industrial equipment, and emergency vehicles. The company was founded by Ellery W. Roberts on January 22, 2013 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts ElleryChairman and CEOSep 07 '23Buy0.0770,0004,945616,430Sep 07 04:14 PM
Roberts ElleryChairman and CEOAug 23 '23Buy0.1240,0004,680546,430Aug 23 04:16 PM
Roberts ElleryChairman and CEOAug 22 '23Buy0.1435,0004,795506,430Aug 23 04:16 PM
Strategic Risk, LLC.10% OwnerAug 17 '23Buy0.1473,62910,0803,894,507Aug 17 01:37 PM
Roberts ElleryChairman and CEOAug 16 '23Buy0.1435,0004,900471,430Aug 17 04:01 PM
GNLX - Genelux Corp - Stock Price Chart
TickerGNLX [NASD, RUT]
CompanyGenelux Corp
CountryUSA
IndustryBiotechnology
Market Cap75.33MEPS (ttm)-0.97
P/E-EPS this Y20.91%
Forward P/E-EPS next Y-29.34%
PEG-EPS past 5Y-23.84%
P/S7533.00EPS next 5Y-
P/B4.99EPS Q/Q30.73%
Dividend-Sales Q/Q-95.29%
Insider Own25.33%Inst Own22.36%
Insider Trans-4.46%Inst Trans-
Short Float12.11%EarningsMay 09/a
Analyst Recom1.00Target Price26.00
Avg Volume199.85K52W Range2.50 - 40.98
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szalay Aladar10% OwnerMay 15 '24Sale3.6617,09462,6241,139,821May 15 05:59 PM
Szalay Aladar10% OwnerMay 14 '24Sale3.5815,42655,2741,156,915May 15 05:59 PM
Szalay Aladar10% OwnerMay 13 '24Sale3.623,44612,4781,172,341May 15 05:59 PM
Szalay Aladar10% OwnerMay 08 '24Sale3.8213,91953,1891,175,787May 09 04:38 PM
Szalay Aladar10% OwnerMay 07 '24Sale3.676,02522,1111,189,706May 09 04:38 PM
STEP - StepStone Group Inc - Stock Price Chart
TickerSTEP [NASD, RUT]
CompanyStepStone Group Inc
CountryUSA
IndustryAsset Management
Market Cap2.92BEPS (ttm)0.92
P/E48.44EPS this Y43.19%
Forward P/E20.53EPS next Y24.95%
PEG2.97EPS past 5Y-13.21%
P/S4.10EPS next 5Y16.30%
P/B8.99EPS Q/Q9.39%
Dividend2.56%Sales Q/Q102.10%
Insider Own15.15%Inst Own83.93%
Insider Trans-5.40%Inst Trans-4.13%
Short Float2.48%EarningsMay 23/a
Analyst Recom2.14Target Price43.89
Avg Volume372.06K52W Range19.63 - 41.80
StepStone Group, Inc. is a private markets investment firm. It focuses on providing customized investment solutions and advisory and data services to clients. The firm serves public and private defined benefit and defined contribution pension funds, sovereign wealth funds and insurance companies, prominent endowments, foundations, family offices and private wealth clients, which include high-net-worth and mass affluent individuals. The company was founded by Monte M. Brem, Jose A. Fernandez, Steve R. Mitchell, Thomas Porter Keck, and Robert A. Waldo in January 2007 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keck ThomasDirectorFeb 26 '24Sale35.473,694131,026200,750Feb 27 07:21 PM
Keck ThomasDirectorFeb 23 '24Sale35.4753,4031,894,204204,444Feb 27 07:21 PM
Keck ThomasDirectorFeb 22 '24Sale35.6848,6621,736,260257,847Feb 22 07:05 PM
Keathley AnthonyChief Accounting OfficerFeb 22 '24Sale35.7046916,7433,183Feb 22 07:11 PM
Keck ThomasDirectorFeb 21 '24Sale35.1024,241850,859306,509Feb 22 07:05 PM
BWEN - Broadwind Inc - Stock Price Chart
TickerBWEN [NASD]
CompanyBroadwind Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap96.05MEPS (ttm)0.39
P/E11.38EPS this Y-69.44%
Forward P/E11.12EPS next Y261.36%
PEG0.47EPS past 5Y-
P/S0.50EPS next 5Y24.00%
P/B1.67EPS Q/Q92.22%
Dividend-Sales Q/Q-23.03%
Insider Own13.31%Inst Own27.16%
Insider Trans0.00%Inst Trans20.84%
Short Float0.93%EarningsMay 14/b
Analyst Recom1.00Target Price6.00
Avg Volume167.02K52W Range2.01 - 4.81
Broadwind, Inc. is engaged in the manufacture of structures, equipment, and components for clean tech and other specialized applications. It operates through the following business segments: Heavy Fabrications, Gearing and Industrial Solutions. The Heavy Fabrications segment provides fabrications to customers in industrial markets. The Gearing segment provides gearing and gearboxes to customers in diverse markets including onshore and offshore oil and gas (O&G) fracking and drilling, surface and underground mining, wind energy, steel, material handling and other industrial markets. The Industrial Solutions segment provides supply chain solutions, inventory management, and kitting and assembly services, primarily serving the combined cycle natural gas turbine market. The company was founded in 1996 and is headquartered in Cicero, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shivaram Sachin MDirectorNov 16 '23Buy2.1810,00021,80064,512Nov 20 05:01 PM
Wagner Thomas A.DirectorSep 06 '23Sale3.9910,00039,92683,683Sep 08 05:01 PM
Kennedy Hayes M.Chief Human Resources OfficerAug 21 '23Buy3.862,5009,65332,725Aug 23 05:02 PM
Press Jeanette A.DirectorAug 21 '23Buy3.9225098013,813Aug 23 05:04 PM
Shivaram Sachin MDirectorAug 18 '23Buy3.6725,94095,24654,512Aug 21 04:42 PM
ADTN - ADTRAN Holdings Inc - Stock Price Chart
TickerADTN [NASD, RUT]
CompanyADTRAN Holdings Inc
CountryUSA
IndustryCommunication Equipment
Market Cap447.82MEPS (ttm)-6.94
P/E-EPS this Y97.88%
Forward P/E16.77EPS next Y1154.69%
PEG-EPS past 5Y-53.24%
P/S0.43EPS next 5Y2.30%
P/B1.68EPS Q/Q-705.06%
Dividend1.59%Sales Q/Q-30.17%
Insider Own6.60%Inst Own81.00%
Insider Trans0.00%Inst Trans42.98%
Short Float4.96%EarningsMay 07/b
Analyst Recom1.86Target Price8.97
Avg Volume773.52K52W Range4.34 - 11.02
ADTRAN Holdings, Inc. develops and provides network access solutions. It is a global provider of open, disaggregated networking and communications equipment that enable voice, data, video and internet communications across any network infrastructure. The company was founded in 1985 and is headquartered in Huntsville, AL.
ADPT - Adaptive Biotechnologies Corp - Stock Price Chart
TickerADPT [NASD, RUT]
CompanyAdaptive Biotechnologies Corp
CountryUSA
IndustryBiotechnology
Market Cap537.90MEPS (ttm)-1.48
P/E-EPS this Y16.91%
Forward P/E-EPS next Y18.03%
PEG-EPS past 5Y-32.91%
P/S3.08EPS next 5Y21.60%
P/B1.96EPS Q/Q18.93%
Dividend-Sales Q/Q11.23%
Insider Own3.52%Inst Own93.79%
Insider Trans-3.38%Inst Trans-3.04%
Short Float9.24%EarningsMay 07/a
Analyst Recom1.50Target Price6.33
Avg Volume1.69M52W Range2.28 - 9.08
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEUPERT PETER MDirectorMar 12 '24Option Exercise0.8415,00012,600169,296Mar 13 05:55 PM
ROBINS CHAD MCEO and ChairmanMar 05 '24Sale3.4348,673167,0072,576,701Mar 06 07:40 PM
RUBINSTEIN JULIEPresidentMar 05 '24Sale3.4739,070135,764472,754Mar 06 07:41 PM
BENZENO SHARONChief Commercial Ofc Imm MedMar 05 '24Sale3.4429,390100,994327,415Mar 06 07:42 PM
PETERSON TYCHOChief Financial OfficerMar 05 '24Sale3.4415,45653,169531,553Mar 06 07:40 PM
12345678910111220